Healthequity Inc（HQY）财务数据HQYHealthequity Inc

Evaluating the bottom line, HealthEquity, Inc. maintains a gross margin of 66.05%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 28.42%, while the net margin is 18.72%. These profitability ratios, combined with a Return on Equity (ROE) of 11.43%, provide a clear picture of how effectively HQY converts its operational activities into shareholder value.

In the context of the broader market, HQY competes directly with industry leaders such as CIGI and VCTR. With a market capitalization of $7.97B, it holds a leading position in the sector. When comparing efficiency, HQY's gross margin of 66.05% stands against CIGI's 35.83% and VCTR's 84.25%. Such benchmarking helps identify whether HealthEquity, Inc. is trading at a premium or discount relative to its financial performance.

HealthEquity has shown consistent revenue growth, with Q2 2026 revenue at $325.8 million and a gross margin of 66.05%, which is an improvement from previous quarters. The company's net income for Q2 2026 was $59.85 million, reflecting strong operational efficiency.